DK680788A - Indolcarboxylsyreestere og -amider, deres fremstilling of laegemidler indeholdende forbindelserne - Google Patents

Indolcarboxylsyreestere og -amider, deres fremstilling of laegemidler indeholdende forbindelserne

Info

Publication number
DK680788A
DK680788A DK680788A DK680788A DK680788A DK 680788 A DK680788 A DK 680788A DK 680788 A DK680788 A DK 680788A DK 680788 A DK680788 A DK 680788A DK 680788 A DK680788 A DK 680788A
Authority
DK
Denmark
Prior art keywords
amides
compounds
preparation
acid esters
indolcarboxylic
Prior art date
Application number
DK680788A
Other languages
English (en)
Other versions
DK680788D0 (da
Inventor
Derk Hamminga
Hans Heinz Haeck
Ineke Van Wijngaarden
Wouter Wouters
Original Assignee
Duphar Int Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duphar Int Res filed Critical Duphar Int Res
Publication of DK680788D0 publication Critical patent/DK680788D0/da
Publication of DK680788A publication Critical patent/DK680788A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
DK680788A 1987-12-10 1988-12-07 Indolcarboxylsyreestere og -amider, deres fremstilling of laegemidler indeholdende forbindelserne DK680788A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8702981 1987-12-10

Publications (2)

Publication Number Publication Date
DK680788D0 DK680788D0 (da) 1988-12-07
DK680788A true DK680788A (da) 1989-06-11

Family

ID=19851068

Family Applications (1)

Application Number Title Priority Date Filing Date
DK680788A DK680788A (da) 1987-12-10 1988-12-07 Indolcarboxylsyreestere og -amider, deres fremstilling of laegemidler indeholdende forbindelserne

Country Status (8)

Country Link
US (1) US4985420A (da)
EP (1) EP0322016A1 (da)
JP (1) JPH01190680A (da)
AU (1) AU621071B2 (da)
DK (1) DK680788A (da)
IL (1) IL88615A (da)
NZ (1) NZ227229A (da)
ZA (1) ZA889166B (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3822792C2 (de) * 1987-07-11 1997-11-27 Sandoz Ag Neue Verwendung von 5HT¶3¶-Antagonisten
US5198437A (en) * 1987-12-10 1993-03-30 Duphar International Research B.V. 1,7-annelated indolecarboxylic acid esters and amides
JPH02180885A (ja) * 1988-09-01 1990-07-13 Glaxo Group Ltd ラクタム誘導体
EP0377238A1 (en) * 1988-12-22 1990-07-11 Duphar International Research B.V New annelated indolo (3,2-c)-lactams
US5223625A (en) * 1988-12-22 1993-06-29 Duphar International Research B.V. Annelated indolo [3,2,-C]lactams
PH26955A (en) * 1989-03-08 1992-12-03 Kali Chemie Pharma Gmbh Novel 1,7-fused 1H-indole-2-carboxylic acid N-(1,4-benzodiazepin-3-YL) amides
DE3907388A1 (de) * 1989-03-08 1990-09-13 Kali Chemie Pharma Gmbh Verfahren zur herstellung von indolcarbonsaeurederivaten
GB8913646D0 (en) * 1989-06-14 1989-08-02 Glaxo Group Ltd Chemical compounds
GB8928837D0 (en) * 1989-12-21 1990-02-28 Beecham Group Plc Pharmaceuticals
EP0436245A1 (en) * 1989-12-27 1991-07-10 Duphar International Research B.V Substituted 3,4-annelated benzimidazol-2(1H)-ones
DE4128015A1 (de) * 1991-08-23 1993-02-25 Kali Chemie Pharma Gmbh 1,7-anellierte 2-(piperazinoalkyl)indol-derivate sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindugnen enthaltende arzneimittel
JPH05310732A (ja) * 1992-03-12 1993-11-22 Mitsubishi Kasei Corp シンノリン−３−カルボン酸誘導体
DE4304806A1 (de) * 1993-02-17 1994-08-18 Kali Chemie Pharma Gmbh 5-Phenyl-pyrrolo-1,4-benzoxazin- und -thiazin-Derivate sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
NZ314105A (en) * 1996-02-02 1997-12-19 Sumitomo Pharma Guanidine derivative substituted with a substituted indole which is peri condensed with a heterocyclic ring
AR036040A1 (es) 2001-06-12 2004-08-04 Upjohn Co Compuestos de heteroarilo multiciclicos sustituidos con quinuclidinas y composiciones farmaceuticas que los contienen
AR036041A1 (es) 2001-06-12 2004-08-04 Upjohn Co Compuestos aromaticos heterociclicos sustituidos con quinuclidina y composiciones farmaceuticas que los contienen
CA2460126A1 (en) 2001-09-21 2003-03-27 Pharmacia & Upjohn Company Tricyclic indole derivatives as 5-ht ligands
CA2466344A1 (en) 2001-11-09 2003-05-22 Pharmacia & Upjohn Company Azabicyclic-phenyl-fused-heterocyclic compounds and their use as alpha7 nachr ligands
DE10164139A1 (de) 2001-12-27 2003-07-10 Bayer Ag 2-Heteroarylcarbonsäureamide
CA3017886A1 (en) 2008-11-19 2010-05-27 Envivo Pharmaceuticals, Inc. Treatment of cognitive disorders with (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof
CN102802620A (zh) * 2009-05-11 2012-11-28 英维沃医药有限公司 使用某种α-7烟酸受体与乙酰胆碱酯酶抑制剂结合治疗认知障碍
US8563567B2 (en) 2009-12-30 2013-10-22 Arqule, Inc. Substituted heterocyclic compounds
WO2011146511A1 (en) 2010-05-17 2011-11-24 Envivo Pharmaceuticals, Inc. A crystalline form of (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate
AU2013259871A1 (en) 2012-05-08 2014-11-20 Forum Pharmaceuticals Inc. Methods of maintaining, treating or improving cognitive function
CN103923105B (zh) * 2014-04-17 2016-08-24 北京大学 2-中氮茚甲酰胺类化合物及其制备和用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI74707C (fi) * 1982-06-29 1988-03-10 Sandoz Ag Foerfarande foer framstaellning av terapeutiskt anvaendbara alkylenoeverbryggade piperidylestrar eller -amider av bicykliska karboxylsyror.
IT1212743B (it) * 1983-05-17 1989-11-30 Dompe Farmaceutici Spa Sali quaternari di derivati di benzo[ 1,4 ]diazepinonici,pirido [1,4]benzodiazepinonici,prido [1,5]benzodiazepinonici e loro atti vita' farmacologica
CY1908A (en) * 1984-12-20 1985-12-13 Sandoz Ag Treatment of gastrointestinal disorders using 5-HT3 antagonists
GB8525844D0 (en) * 1985-10-19 1985-11-20 Beecham Group Plc Compounds
ZA868369B (en) * 1986-01-10 1987-11-25 Israel State Derivatives of quinuclidine

Also Published As

Publication number Publication date
NZ227229A (en) 1991-03-26
IL88615A (en) 1992-11-15
DK680788D0 (da) 1988-12-07
AU621071B2 (en) 1992-03-05
IL88615A0 (en) 1989-07-31
JPH01190680A (ja) 1989-07-31
AU2669688A (en) 1989-06-15
ZA889166B (en) 1990-05-30
US4985420A (en) 1991-01-15
EP0322016A1 (en) 1989-06-28

Similar Documents

Publication Publication Date Title
DK680788D0 (da) Indolcarboxylsyreestere og -amider, deres fremstilling of laegemidler indeholdende forbindelserne
NO862734D0 (no) Fremgangsmaate for fremstilling av hyaluronsyreestere.
PT86819A (pt) Process for the preparation of novel insulin derivatives and of pharmaceutical compositions containing the same
TR23568A (tr) Partikuel halde tuetuenden istifade ederek tuetuen asili malzemelerin ueretilmesi
FI881223A0 (fi) Menetelmä terapeuttisesti aktiivisten substituoitujen 9-aminotetrahydroakriinien ja niille läheisten yhdisteiden valmistamiseksi
NO864425L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocyklyl-oksoftalazinyl-eddiksyre-derivater
ATE142205T1 (de) Substituierte piperidimylmethyl-ester von 3- indolcarbonsäure
NO176273C (no) Analogifremgangsmåte for fremstilling av aktive substituerte benzamider
PT87153A (pt) Process for the preparation of acid ribofuranuronic derivatives
NO862141L (no) Fremgangsmaate for fremstilling av aktive cinnolinderivater
PT87024A (pt) Process for the preparation of propiolophenone derivatives and of pharmaceutical compositions containing the same
IL79964A0 (en) Process for the preparation of optically active alpha-phenoxy-propionic acid and its derivatives
ZA891534B (en) Process for the preparation of optically active 4-oxo-1-benzopyran-2-carboxylic acid derivatives and intermediates thereof
PT86776A (pt) Process for the preparation of piperazinecarboxylic acid and pharmaceutical compositions containing it
FI890477A0 (fi) Menetelmä terapeuttisesti käyttökelpoisen 2,5-diamino-6-fluoriheksaanihapon ja sen suolojen valmistamiseksi
NO893165D0 (no) Fremstilling av klorsyre.
IT8919339A0 (it) Procedimento per la preparazione di acido n fosfonometiliminodiacetico e di cloruri di acidi.
DK560989A (da) Anvendelse af ethylendiamintetraeddikesyre til fremstilling af laegemidler
ZA856402B (en) Process for the preparation of optically active,substituted 1,4-dihydropyridines and their use as medicaments
DE69305250D1 (de) Herstellung von Alkandicarbonsäurederivaten
DK320288D0 (da) Sakkaroaskorbinsyreestere samt fremstilling og anvendelse deraf
NO924763L (no) Ny fremgangsmaate for fremstilling av 4-amino-5-hexensyre
DK576687A (da) Terapeutisk aktive alkensyrederivater
PT87573A (pt) Process for the preparation of amidas pyrazine and of pharmaceutical compounds containing them
DK580288A (da) Farmaceutisk praeparat indeholdende imidazol-2-thioncarboxamider

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment